Next Century Growth Investors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Next Century Growth Investors’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-217,455	Closed	-$3.32M	–	196
2014 Q3	$3.32M	Sell	217,455 -42,427	-16%	-$650K	0.12%	159
2014 Q2	$4.37M	Sell	259,882 -41,083	-14%	-$740K	0.14%	150
2014 Q1	$6.04M	Buy	+300,965	New	+$6.51M	0.18%	139

Other funds holding OXFD

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Next Century Growth Investors's OXFD Position: Q4 2014 in Review

Next Century Growth Investors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2014, closing a stake of 217,455 shares — an estimated $3.32M sold.

Next Century Growth Investors first reported a position in OXFD in Q1 2014 and held it in 3 quarters. The position peaked at $6.04M in Q1 2014. 49 funds tracked by Wall St. Rank hold OXFD as of Q4 2014.

Next Century Growth Investors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2014 after selling out during the quarter.
Next Century Growth Investors sold 217,455 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2014, an estimated $3.32M.
Next Century Growth Investors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 3 quarters.
Next Century Growth Investors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $6.04M in Q1 2014.
49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2014.

Based on Next Century Growth Investors's 13F filing for Q4 2014, filed 13 Feb 2015.